GENFIT (XUP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:XUP - FR0004163111 - Common Stock
5.26 EUR
+0.05 (+1.06%)
Taking everything into account, XUP scores 2 out of 10 in our fundamental rating. XUP was compared to 86 industry peers in the Biotechnology industry. While XUP seems to be doing ok healthwise, there are quite some concerns on its profitability. XUP is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year XUP has reported negative net income.
- In the past year XUP has reported a negative cash flow from operations.
- The reported net income has been mixed in the past 5 years: XUP reported negative net income in multiple years.
- In multiple years XUP reported negative operating cash flow during the last 5 years.
1.2 Ratios
- XUP's Return On Assets of -17.98% is fine compared to the rest of the industry. XUP outperforms 61.63% of its industry peers.
- XUP's Return On Equity of -74.24% is in line compared to the rest of the industry. XUP outperforms 58.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.98% | ||
| ROE | -74.24% | ||
| ROIC | N/A |
ROA(3y)-8.88%
ROA(5y)-10.74%
ROE(3y)-21.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- XUP's Profit Margin has declined in the last couple of years.
- XUP's Operating Margin has declined in the last couple of years.
- XUP has a better Gross Margin (95.42%) than 94.19% of its industry peers.
- In the last couple of years the Gross Margin of XUP has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for XUP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 95.42% |
OM growth 3Y-50.59%
OM growth 5YN/A
PM growth 3Y-69.99%
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y0.52%
2. Health
2.1 Basic Checks
- XUP does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, XUP has more shares outstanding
- Compared to 5 years ago, XUP has more shares outstanding
- Compared to 1 year ago, XUP has a worse debt to assets ratio.
2.2 Solvency
- XUP has an Altman-Z score of -1.21. This is a bad value and indicates that XUP is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of XUP (-1.21) is worse than 61.63% of its industry peers.
- XUP has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
- XUP's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. XUP outperforms 65.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.21 |
ROIC/WACCN/A
WACC7.37%
2.3 Liquidity
- XUP has a Current Ratio of 3.74. This indicates that XUP is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 3.74, XUP is doing good in the industry, outperforming 70.93% of the companies in the same industry.
- XUP has a Quick Ratio of 3.74. This indicates that XUP is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of XUP (3.74) is better than 77.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.74 | ||
| Quick Ratio | 3.74 |
3. Growth
3.1 Past
- XUP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -289.19%.
- Measured over the past years, XUP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -70.77% on average per year.
- Looking at the last year, XUP shows a very negative growth in Revenue. The Revenue has decreased by -45.94% in the last year.
- XUP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.61% yearly.
EPS 1Y (TTM)-289.19%
EPS 3Y-70.77%
EPS 5YN/A
EPS Q2Q%-137.74%
Revenue 1Y (TTM)-45.94%
Revenue growth 3Y-6.06%
Revenue growth 5Y11.61%
Sales Q2Q%-45.28%
3.2 Future
- XUP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.44% yearly.
- Based on estimates for the next years, XUP will show a decrease in Revenue. The Revenue will decrease by -1.87% on average per year.
EPS Next Y-229.07%
EPS Next 2Y-97.6%
EPS Next 3Y-36.76%
EPS Next 5Y-29.44%
Revenue Next Year-34.41%
Revenue Next 2Y-21.78%
Revenue Next 3Y-8%
Revenue Next 5Y-1.87%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- XUP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XUP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as XUP's earnings are expected to decrease with -36.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-97.6%
EPS Next 3Y-36.76%
5. Dividend
5.1 Amount
- XUP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GENFIT / XUP.DE FAQ
What is the fundamental rating for XUP stock?
ChartMill assigns a fundamental rating of 2 / 10 to XUP.DE.
What is the valuation status of GENFIT (XUP.DE) stock?
ChartMill assigns a valuation rating of 0 / 10 to GENFIT (XUP.DE). This can be considered as Overvalued.
How profitable is GENFIT (XUP.DE) stock?
GENFIT (XUP.DE) has a profitability rating of 2 / 10.
What is the expected EPS growth for GENFIT (XUP.DE) stock?
The Earnings per Share (EPS) of GENFIT (XUP.DE) is expected to decline by -229.07% in the next year.